Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET

Company Participants

Nathan Smith - Senior Vice President, Investor Relations

Paul Diaz - President & Chief Executive Officer

Bryan Riggsbee - Chief Financial Officer

Nicole Lambert - Chief Operating Officer

Conference Call Participants

Jack Meehan - Nephron Research

Kyle Boucher - Cowen

Operator

Greetings and welcome to the Myriad Genetics First Quarter 2022 Financial Earnings Call. During the presentation, all participants will be in a listen-only mode. Afterwards we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today Thursday, May 5 2022.

I'd now like to turn the call over to Nathan Smith, Senior Vice President of Investor Relations. Please go ahead.

Nathan Smith

All right. Thank you Dave. Good afternoon and welcome to the Myriad Genetics first quarter 2022 earnings call. During the call, we will review the financial results we released today. And afterwards we will host a question-and-answer session. Our quarterly earnings release was issued this morning on Form 8-K and can be found on our website at investor.myriad.com.

I'm Nathan Smith, Senior Vice President of Investor Relations and Treasury. On the call with me today are Paul Diaz, our President and Chief Executive Officer; Bryan Riggsbee, our Chief Financial Officer; and Nicole Lambert, our Chief Operating Officer. This call can be heard live via webcast at investor.myriad.com and a recording will be archived in the Investors section of our website. In addition, following the call, the slide presentation will be available on the Investors section of our website.

Please note that some of the information presented today may contain projections or other forward-looking statements regarding future events or the future financial performance of the company. These statements are based on management's current expectations and the actual events or results may differ materially and adversely from these expectations for a variety of reasons. We refer you to the documents the company files from time to time with the Securities and Exchange Commission. Specifically, the company's annual transition report on Form 10-K, it's quarterly reports on Form 10-Q and it's current reports on Form 8-K. These documents identify important risk factors that could cause the actual results to differ materially from those contained in our projections or forward-looking statements.

With that I will now turn the time over to Paul.

Paul Diaz

Thanks Nathan. Good afternoon everyone and thank you for joining us. On today's call, we will discuss our Q1 results along with highlights from the quarter and updates on our strategic transformation and growth plan.